Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Moscow, 115446, Russia
NCT Number: NCT05543811
This is a single-centre, single-blind, two-arms, controlled study to assess the efficacy and safety of food for special dietary use enriched with 5-hydroxytryptophan, L-theanine and Gamma-aminobutyric acid in generally healthy subjects with no cognitive disturbances
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Moscow, 115446, Russia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Food for special dietary use (spread) with modified ingredients' content will be included to the diet of 70 patients without significant organic pathology for 14 days receiving standard diet, modified by the inclusion of two portions of the spread, 20 grams each for breakfast and dinner
Time frame: two weeks
change in score by Lurie test
Time frame: two weeks
change in Kraepelin&Schulte test score
Time frame: two weeks
change in functional status test score
Time frame: two weeks
change in Beck depression inventory score
Time frame: two weeks
change in food's taste monotony
Federal State Budgetary Scientific Institution
Other Gov
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Disorders
Acronym: Spread Bogatyr
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03246269
Alzheimer Disease, Brain Diseases
View Trial DetailsNCT05201534
Behavior, Behavior and Behavior Mechanisms
Palo Alto, California, United States
View Trial DetailsNCT05177679
Achievement, Cognitive Change
Urbana, Illinois, United States
View Trial DetailsNCT05138848
Alzheimer Disease, Alzheimer Disease, Late Onset
Pittsburgh, Pennsylvania, United States
View Trial Details